paeonol has been researched along with paclitaxel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Chen, S; Dong, Y; Hu, S; Lu, J; Xing, J; Zhang, W | 1 |
| Cai, J; Chen, S; Dong, W; Dong, Y; Hu, S; Lu, J; Xing, J; Zhang, W; Zheng, X | 1 |
2 other study(ies) available for paeonol and paclitaxel
| Article | Year |
|---|---|
Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2.
Topics: Acetophenones; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; MCF-7 Cells; Microfilament Proteins; Multidrug Resistance-Associated Proteins; Muscle Proteins; Neoplasm Proteins; Paclitaxel; Promoter Regions, Genetic; Up-Regulation | 2014 |
Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.
Topics: Acetophenones; Apoptosis; Breast Neoplasms; DNA-Binding Proteins; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Histone Chaperones; Humans; MCF-7 Cells; Oncogene Protein v-akt; Paclitaxel; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Signal Transduction; Transcription Factors | 2015 |